Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gray

Showing results (1461-1470 of 1,482) with videos related to

Pageof 149
Sort By:
Plos One|April 25, 2009
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02AMichele D Spring, James F Cummings, Christian F Ockenhouse, et al.
Plos One|January 24, 2008
Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trialMahamadou A Thera, Ogobara K Doumbo, Drissa Coulibaly, et al.
Plos One|February 9, 2010
Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trialMahamadou A Thera, Ogobara K Doumbo, Drissa Coulibaly, et al.
Cancer Discovery|December 7, 2018
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast CancerSheau W Lok, James R Whittle, François Vaillant, et al.
Npj Viruses|April 28, 2025
Pathogenesis and transmission of SARS-CoV-2 D614G, Alpha, Gamma, Delta, and Omicron variants in golden hamstersAndra Banete, Bryan D Griffin, Juan C Corredor, et al.
Thorax|February 12, 2013
Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbationAlex R Horsley, Jane C Davies, Robert D Gray, et al.
Science Immunology|October 9, 2020
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patientsBaweleta Isho, Kento T Abe, Michelle Zuo, et al.
Microbiology Resource Announcements|July 15, 2021
Genome Sequences of Akoni, Ashton, and Truong, <i>Podoviridae</i> Bacteriophages Isolated from Microbacterium foliorumFadia Fakhre, Raquel M Gonzalez, Elisabeth K Howells, et al.
Plos One|November 22, 2013
Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trialMatthew B Laurens, Mahamadou A Thera, Drissa Coulibaly, et al.
Emerging Microbes & Infections|October 26, 2022
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, et al.
Pageof 149

Showing results (1461-1470 of 1,482) with videos related to

Sort By:
Pageof 149
Plos One|April 25, 2009
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02AMichele D Spring, James F Cummings, Christian F Ockenhouse, et al.
Plos One|January 24, 2008
Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trialMahamadou A Thera, Ogobara K Doumbo, Drissa Coulibaly, et al.
Plos One|February 9, 2010
Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trialMahamadou A Thera, Ogobara K Doumbo, Drissa Coulibaly, et al.
Cancer Discovery|December 7, 2018
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast CancerSheau W Lok, James R Whittle, François Vaillant, et al.
Npj Viruses|April 28, 2025
Pathogenesis and transmission of SARS-CoV-2 D614G, Alpha, Gamma, Delta, and Omicron variants in golden hamstersAndra Banete, Bryan D Griffin, Juan C Corredor, et al.
Thorax|February 12, 2013
Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbationAlex R Horsley, Jane C Davies, Robert D Gray, et al.
Science Immunology|October 9, 2020
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patientsBaweleta Isho, Kento T Abe, Michelle Zuo, et al.
Microbiology Resource Announcements|July 15, 2021
Genome Sequences of Akoni, Ashton, and Truong, <i>Podoviridae</i> Bacteriophages Isolated from Microbacterium foliorumFadia Fakhre, Raquel M Gonzalez, Elisabeth K Howells, et al.
Plos One|November 22, 2013
Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trialMatthew B Laurens, Mahamadou A Thera, Drissa Coulibaly, et al.
Emerging Microbes & Infections|October 26, 2022
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, et al.
Pageof 149